Pharmacists use smart sensors to fight prediabetes
NCT ID NCT07529366
First seen Apr 17, 2026 · Last updated Jun 22, 2026 · Updated 16 times
Summary
This study tests whether a pharmacist-led program using a continuous glucose monitor (CGM) can help people with prediabetes better control their blood sugar and make healthier choices. Forty adults with prediabetes will wear a CGM sensor for 12 weeks and receive pharmacist guidance. Researchers will compare their blood sugar changes to a historical group that did not use CGM.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREDIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
USF Health Department of Family Medicine - Morsani Center for Advanced Health Care
RECRUITINGTampa, Florida, 33612, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
USF Health Department of Family Medicine - University Partnership Center
RECRUITINGTampa, Florida, 33613, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Dexcom Stelo continuous glucose monitor (CGM) device
What this could lead to
If successful, this could show that pharmacist-guided CGM helps people with prediabetes lower their blood sugar and adopt healthier habits.
What could go wrong
This is a small, early study with only 40 participants and no random assignment, so results may not apply broadly. The device is for monitoring, not treatment.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.